COMP <GO>
ZJYL vs INGN // EV/EBITDA & P/E VALUATION
JIN MEDICAL INTERNATIONAL LTD. (Class A) (NASDAQ) VS. Inogen Inc (NASDAQ) • 15-METRIC TALLY: ZJYL 3
— INGN 4
■ METRIC PARITY
LAST: $1.86 (-2.10%) • MKT CAP: $294.2M
valuation
47.1x
LAST: $7.26 (+0.14%) • MKT CAP: $192.7M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ZJYL VS. INGN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ZJYL | INGN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 29.20% | 52.20% | -23.00 | INGN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -27.00% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 47.1x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -1.27% | -7.13% | +5.86 | ZJYL | /fcf-yield <GO> |
| Operating Margin | 2.90% | -10.20% | +13.10 | ZJYL | /operating-margins <GO> |
| Net Profit Margin | 5.80% | 7.70% | -1.90 | INGN | /net-margins <GO> |
| Revenue Growth (YoY) | -12.00% | 5.90% | -17.90 | INGN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 1.46 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 4/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.0 | 61.6 | -0.68 | INGN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 7.9x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $294.2M | $192.7M | $101.6M | ZJYL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ZJYL REV | INGN REV | ZJYL GROSS % | INGN GROSS % | ZJYL FCF | INGN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $20.7M | $295.3M | 29.2% | 52.2% | -$3.7M | -$13.7M |
| FY 2024 | $23.5M | $278.8M | 40.4% | 55.5% | -$1.4M | $2.6M |
| FY 2023 | $19.8M | $251.6M | — | — | $3.1M | -$3.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ZJYL // BETA —
INGN // BETA —